New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
›ETF Issuers›iShares›XDNA
XDNA

iShares Genomics Immunology and Healthcare Index ETF

Passive ETFEquityTheme: BioTech & Genomics

The XDNA Exchange Traded Fund (ETF) is provided by iShares. It is built to track an index: NYSE FactSet Global Genomics and Immuno Biopharma Index. The XDNA ETF provides physical exposure, so by buying it you actually own parts of all the 49 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

Diversification
Data as of 05/31/26
No. of holdings
49
Effective diversification
27.8
Total weight of top 15 holdings
65.27%
Top 15 Holdings
Data as of 05/31/26
Revolution Medicines, Inc.
7.39%
Moderna, Inc.
6.36%
Ipsen SA
4.81%
Merck & Co., Inc.
4.44%
Twist Bioscience Corp.
4.27%
Exelixis, Inc.
4.25%
Takeda Pharmaceutical Co., Ltd.
4.21%
Bayer AG
4.10%
Roche Holding AG
4.06%
GSK Plc
3.93%
BioNTech SE
3.72%
Vertex Pharmaceuticals, Inc.
3.68%
Incyte Corp.
3.53%
Sanofi
3.31%
Regeneron Pharmaceuticals, Inc.
3.21%
Sector exposures
Data as of 05/31/26
Healthcare
Unavailable
020%40%60%80%100%
Country exposures
Data as of 05/31/26
USA
France
Germany
Japan
Switzerland
United Kingdom
Denmark
China
Unavailable
Other
020%40%60%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
ETF TOOLS
ETF ScreenerCompare ETFsCompare ETF issuersWatchlistsETF Portfolio InsightsIndustry dataETF stock exposure finder
PLATFORM
Support and feedback
ETF NEWS & RESEARCH
Latest ETF NewsETF Research ReportsGlobal ETF Survey 2025Learn ETF investing
PROFESSIONAL SOLUTIONS
Enterprise SolutionsDue Diligence ServicesETF Data Services
SOLUTIONS FOR
Institutional investorsPrivate banksFinancial advisorsFintech and mediaIndividual investors
CONTACT US
General inquiries
Press and media
Advertising opportunities
Support and feedback
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Get our newsletters
Trackinsight